Assessment of an Oral Corticosteroid Withdrawal Pathway for Severe Asthma Patients Receiving Biologic Therapies
Most clinically stable patients with asthma receiving biologics successfully withdrew mOCS without requiring dynamic adrenal function testing.
Authors
- Salman Siddiqui (ORCID: https://orcid.org/0000-0003-3770-7870)
- Miles Levy (ORCID: https://orcid.org/0000-0001-7256-7880)
- Karim Meeran (ORCID: https://orcid.org/0000-0002-7112-2756)
- Claire Boddy
- Peter Bradding (ORCID: https://orcid.org/0000-0001-8403-0319)
- Kumaran Balasundaram (ORCID: https://orcid.org/0009-0003-1119-4146)
- Richard Russell (ORCID: https://orcid.org/0000-0002-0195-0812)
- Syed F. Mohammad
- Hnin Aung (ORCID: https://orcid.org/0009-0004-1083-1147)
- Mark Bell
- Eleanor Hampson
- Lauren Parnell (ORCID: https://orcid.org/0000-0001-8147-7713)
- Shamsa Naveed
- Michelle A Bonnington
Institutions
- Hammersmith Hospital (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Lung Institute (US)
- NIHR Imperial Biomedical Research Centre (GB)
- NIHR Royal Brompton Cardiovascular Biomedical Research Unit (GB)
- NIHR Leicester Biomedical Research Centre (GB)
- Imperial College London (GB)
Publication Details
- Journal
- The Journal of Allergy and Clinical Immunology In Practice
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.jaip.2025.03.048
- Citations
- 4
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 13.98